In a review of existing literature on the role of CD44/CD24 in recurrent human cancer, investigators showed positive associations between CD44+/CD24- and prognosis, especially in breast cancer; and the CD44+/CD24- phenotype of breast cancer cells was also associated with invasive properties. Here, CD44 is linked to breast cancer.